JP2024532810A5 - - Google Patents
Info
- Publication number
- JP2024532810A5 JP2024532810A5 JP2024508786A JP2024508786A JP2024532810A5 JP 2024532810 A5 JP2024532810 A5 JP 2024532810A5 JP 2024508786 A JP2024508786 A JP 2024508786A JP 2024508786 A JP2024508786 A JP 2024508786A JP 2024532810 A5 JP2024532810 A5 JP 2024532810A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antigen
- combination
- pharmaceutically acceptable
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163233163P | 2021-08-13 | 2021-08-13 | |
| US63/233,163 | 2021-08-13 | ||
| PCT/US2022/074903 WO2023019242A1 (en) | 2021-08-13 | 2022-08-12 | Compositions and methods for reducing immune intolerance and treating autoimmune disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532810A JP2024532810A (ja) | 2024-09-10 |
| JP2024532810A5 true JP2024532810A5 (cg-RX-API-DMAC7.html) | 2025-08-19 |
Family
ID=83192025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508786A Pending JP2024532810A (ja) | 2021-08-13 | 2022-08-12 | 免疫不寛容を軽減し、自己免疫障害を治療するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240351977A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4384495A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024532810A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240046744A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118076582A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3228238A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023019242A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12697320B2 (en) | 2021-01-29 | 2026-08-04 | Tim Therapeutics, Inc. | Tartaric acid analogs and uses thereof |
| CN117940407A (zh) | 2021-08-13 | 2024-04-26 | Lapix生物治疗股份有限公司 | 降低免疫不耐受和治疗自身免疫病症的组合物和方法 |
| US20260144239A1 (en) | 2022-10-25 | 2026-05-28 | Lapix Therapeutics, Inc. | Immune Cell-Engrafted Non-Human Animals and Non-Human Animal Models |
| WO2024118602A1 (en) | 2022-11-29 | 2024-06-06 | Lapix Therapeutics, Inc. | Compositions and methods for reducing immune intolerance and treating autoimmune disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8859284B2 (en) * | 2009-10-22 | 2014-10-14 | The United States Of America, As Represented By The Secretary Of The Navy | Delivery of nanoparticles to neurons |
| EP2638896A1 (en) * | 2012-03-14 | 2013-09-18 | Bioneer A/S | Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood |
| JP6783652B2 (ja) * | 2013-09-24 | 2020-11-11 | ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク | 抗原特異的免疫原性を低減するための組成物及び方法 |
| ES2952038T3 (es) * | 2016-04-05 | 2023-10-26 | Univ New York State Res Found | Composiciones que contienen fosfoserina para la inducción de la tolerancia inmune |
| US20240173389A1 (en) * | 2021-03-11 | 2024-05-30 | Lapix Therapeutics, Inc. | Compositions and Methods For Reducing Immune Intolerance |
-
2022
- 2022-08-12 EP EP22764981.1A patent/EP4384495A1/en active Pending
- 2022-08-12 KR KR1020247007625A patent/KR20240046744A/ko active Pending
- 2022-08-12 CN CN202280068028.1A patent/CN118076582A/zh active Pending
- 2022-08-12 JP JP2024508786A patent/JP2024532810A/ja active Pending
- 2022-08-12 CA CA3228238A patent/CA3228238A1/en active Pending
- 2022-08-12 US US18/579,943 patent/US20240351977A1/en active Pending
- 2022-08-12 WO PCT/US2022/074903 patent/WO2023019242A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022530018A5 (cg-RX-API-DMAC7.html) | ||
| Greco et al. | Sudden sensorineural hearing loss: an autoimmune disease? | |
| JP5555431B2 (ja) | 自己免疫疾患を予防し治療するための物質 | |
| JP4782675B2 (ja) | ワクチン接種用スフィンゴイドポリアルキルアミン抱合体 | |
| ES2893451T3 (es) | ARN para el tratamiento de enfermedades autoinmunes | |
| AKBAR et al. | Hepatitis B virus (HBV)‐transgenic mice as an investigative tool to study immunopathology during HBV infection | |
| CA2198479A1 (fr) | Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique | |
| JP2001502299A (ja) | リポソーム | |
| JP2004331668A (ja) | 生物活性ペプチドをコードする裸のポリヌクレオチドを投与するための医薬、組成物およびシステム | |
| CN103118697A (zh) | 治疗肿瘤形成的免疫原性组合物及方法 | |
| US20220273791A1 (en) | Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentation | |
| WO2000040273A2 (en) | Treatment of viral diseases using an interferon omega expressing polynucleotide | |
| CN118076582A (zh) | 降低免疫不耐受和治疗自身免疫病症的组合物和方法 | |
| Xia et al. | Lung gene therapy—How to capture illumination from the light already present in the tunnel | |
| TW202302855A (zh) | 用於治療法布瑞氏症之組成物及方法 | |
| JP2025516637A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2022244815A5 (cg-RX-API-DMAC7.html) | ||
| WO2023280303A1 (zh) | Avc-29作为疫苗佐剂的用途以及含有该佐剂的疫苗组合物 | |
| ES2292594T3 (es) | E-selectina para tratar o prevenir accidentes cerebrovasculares. | |
| JP2023513487A5 (cg-RX-API-DMAC7.html) | ||
| JP2025505628A5 (cg-RX-API-DMAC7.html) | ||
| JP2025506429A5 (cg-RX-API-DMAC7.html) | ||
| AU2001264813A1 (en) | Methods for preventing strokes by inducing tolerance to E-selectin | |
| JP2025516636A5 (cg-RX-API-DMAC7.html) | ||
| US20250170272A1 (en) | Polyomaviral gene delivery vector particle comprising a nucleic acid sequence encoding a phosphatase activity-possessing polypeptide |